ABOUT

Pharma Live Expo & Summit 2025

Pharma Live is the ideal business platform for International Pharma professionals to have meaningful deliberations and networking with the ever growing Indian Pharmaceutical industry. Organised jointly by the Indian Drug Manufacturers’ Association and Icexpo Consults the Pharma Live 2025 edition hosted 206 exhibitors with 10,000+ product display covering pharmaceutical formulations, APIs, drug intermediates, contract manufacturing, Pharma and packaging machineries and other ancillary industry to Pharma. The exhibition has attracted visitors from 36 countries. The hosted buyer-seller meet attracted 147 buyer companies from 24 African nations.

Exhibitor

Visitor

Mumbai to Host Pharma Live Expo 2025.

The show is once again hosted at the commercial capital of India- Mumbai and the Bombay Exhibition Centre, NESCO, Mumbai will once again be the choice of Venue. The three days of exhibition and summit is supported by various industrial associations such as Pharmexcil, BDMAI, FOPE, FPME, AHNMI and organised under the aegis of Department of Pharmaceuticals, Ministry of Chemical & Fertilisers, Govt. of India.

Contact

Exhibition

Awards

Conference

B2B Meetings

RBSM

WHY SHOULD YOU BE A PART OF PHARMA LIVE EXPO 2025 ?

DEMAND

Over US$ 200 billion to be spent on medical infrastructure in the next decade.
New business models expected to penetrate tier-2 and 3 cities.
Over 160,000 hospital beds expected to be added each year in the next decade.
India’s generic drugs account for 20% of global exports in terms of volume, making the country the largest provider of generic medicines globally.

GROWTH

India’s pharmaceutical export stood at US$ 16.28 billion in FY20.
Indian pharmaceutical sector is expected to grow at a CAGR of 22.4% in the near future and medical device market expected to grow US$ 25 billion by 2025.
The pharmaceutical sector was valued at US$ 33 billion in 2017.
Indian health care sector,one of the fastest growing sectors, is expected to cross US$ 372 billion by 2022.

OPPORTUNITIES

Due to a genetically diverse population and availability of skilled doctors, India has the potential to attract huge investments to its clinical trial market.
Due to increasing population and income levels, demand for high-end drugs is expected to rise.
rowing demand could open up the market for production of high-end drugs in India.
With 70% of India’s population residing in rural areas, pharma companies have immense opportunities to tap this market.

GOVT SUPPORT

With 70% of India’s population residing in rural areas, pharma companies have immense opportunities to tap this market.
Government is planning to relax FDI norms in the pharmaceutical sector.
Government of India is planning to set up mega bulk drug parks in order to reduce industry’s dependency on raw material imports.
In September 2020, the government announced production linked incentive (PLI) scheme for the pharmaceutical industry worth Rs. 15,000 crore (US$ 2.04billion).

PROFILES

THE COMPLETE PHARMACEUTICAL ECOSYSTEM

Pharma Live Expo would be the first of its kind being organised at the commercial capital of India- Mumbai. The three days of business extravagance will have more than 300 plus exhibitors and about 700 plus products on display. Mumbai - being the gateway to Indian pharmaceutical industry, the expo will witness 8000+ business delegates from all parts of the globe.

Visitor Profile

Plant Management
Plant Engineering
Manufacturing/ Production ocers/ Formulations
Maintenance Engineering
Packaging
Pharmacists
Contract Manufacturers

Exhibitor Profile

Pharma Processing Machineries (Tablet / Capsule / Liquid/ Injectable / Ointment / Dry Syrup)
Packaging Machineries, Packaging Materials & Consumables
Environment Control Equipment/ Services, Clean room Partitions, Equipment, Furniture & Services